Impact of Bortezomib Incorporated Into Autotransplantation On Outcomes of Myeloma Patients with High-Risk Cytogenetics: An Integrated Analysis of 1894 Patients Enrolled in Four European Phase 3 Studies
暂无分享,去创建一个
H. Goldschmidt | P. Sonneveld | J. Miguel | P. Moreau | H. Avet-Loiseau | N. Gutiérrez | G. Marit | T. Facon | J. Harousseau | J. Bladé | J. Lahuerta | H. Lokhorst | L. Rosiñol | A. Palumbo | M. Petrucci | F. Patriarca | M. Attal | H. Salwender | M. Cavo | C. Terragna | B. Holt | M. Martín | G. Marzocchi | Wolgang Igor Blau